⌘K

Home/Filings/4/0001127602-19-033004

4//SEC Filing

Babu Yarlagadda S 4

Accession 0001127602-19-033004

CIK 0000882796other

View on SEC.gov Company Profile

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 4:03 PM ET

Size

4.2 KB

Accession

0001127602-19-033004

Insider Transaction Report

Form 4

Period: 2019-11-18

BIOCRYST PHARMACEUTICALS INCBCRX

Babu Yarlagadda S

VP Drug Discovery

Transactions

Purchase
Common Stock
2019-11-18$1.45/sh+25,000$36,250→ 155,587 total

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1

filerCIK 0001452635

Filing Metadata

Form type: 4
Filed: Nov 17, 7:00 PM ET
Accepted: Nov 18, 4:03 PM ET
Size: 4.2 KB

View on SEC.gov